哈佛生物科学宣布首席执行官继任计划

• Harvard Bioscience (NASDAQ:HBIO) announced a CEO succession plan under which John Duke will assume the role of president & CEO following the planned retirement of Jim Green, effective July 28, 2025.
• Jim Green will be retiring from his President, CEO & Chairman roles at Harvard Bioscience after more than 8 years as Chairman and 6 years as President & CEO.
• Mr. Duke is a member of the Board of Directors of Harvard Bioscience (NASDAQ:HBIO) and CEO of Plastic Molding Technology.
• The company also announced the appointment of Rob Gagnon and Seth Benson as new Board members.

More on Harvard Bioscience

• Harvard Bioscience, Inc. (HBIO) Q1 2025 Earnings Call Transcript
• Harvard Bioscience, Inc. 2025 Q1 - Results - Earnings Call Presentation
• Harvard Bioscience outlines Q2 revenue target of $18M–$20M amid product launches and cost actions
• Seeking Alpha’s Quant Rating on Harvard Bioscience
• Historical earnings data for Harvard Bioscience